(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (Q4129234): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in fr, and other parts: Adding French translations) |
(Changed label, description and/or aliases in de, and other parts: Adding German translations) |
||||||||||||||
| label / de | label / de | ||||||||||||||
(0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE | |||||||||||||||
| Property / summary | |||||||||||||||
(0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE (German) | |||||||||||||||
| Property / summary: (0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE (German) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: (0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE (German) / qualifier | |||||||||||||||
point in time: 3 February 2022
| |||||||||||||||
Revision as of 06:48, 3 February 2022
Project Q4129234 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION |
Project Q4129234 in Italy |
Statements
5,000.0 Euro
0 references
10,000.0 Euro
0 references
50.0 percent
0 references
LOGIDEX SRL
0 references
(0350000119) COVID:REALIZZAZIONE DI UN COLLUTORIO A BASE DI RESVERATROLO COMPLESSATO CON CICLODESTRINE PER PREVENIRE IL DIFFONDERSI DEL SARS-COV-2 MEDIANTE AEROSOL SALIVARE: SPERIMENTAZIONE PRECLINICA (Italian)
0 references
(0350000119) COVID:REALIZZAZIONE DE UN ENJUAGUE BUCAL A BASE DE RESVERATROL COMPLEJO CON CICLODEXTRINA PARA PREVENIR LA PROPAGACIÓN DEL SARS-COV-2 POR AEROSOLES SALIVALES: EXPERIMENTACIÓN PRECLÍNICA (Spanish)
30 January 2022
0 references
(0350000119) COVID:REALIZZAZIONE OF A RESVERATROL-BASED MOUTHWASH COMPLEXED WITH CYCLODEXTRIN TO PREVENT THE SPREAD OF SARS-COV-2 BY SALIVARY AEROSOLS: PRECLINICAL EXPERIMENTATION (English)
31 January 2022
0 references
(0350000119) COVID:REALIZZAZIONE D’UN BAIN DE BOUCHE À BASE DE RESVÉRATROL COMPLEXE AVEC DE LA CYCLODEXTRINE POUR PRÉVENIR LA PROPAGATION DU SARS-COV-2 PAR LES AÉROSOLS SALIVAIRES: EXPÉRIMENTATION PRÉCLINIQUE (French)
1 February 2022
0 references
(0350000119) COVID:REALIZZAZIONE EINER RESVERATROL-BASIERTEN MUNDSPÜLUNG, DIE MIT CYCLODEXTRIN KOMPLEX IST, UM DIE AUSBREITUNG VON SARS-COV-2 DURCH SPEICHELAEROSOLE ZU VERHINDERN: PRÄKLINISCHE EXPERIMENTE (German)
3 February 2022
0 references
TORINO
0 references